Microgyn

Ethinylestradiol and Levonorgestrel, the active ingredients in Microgyn, are a combined oral contraceptive presented as a tablet for oral use. They work together to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Microgyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory requirements and is manufactured under GMP conditions, ensuring consistent potency and safety for patients. It is distributed through a secure logistics network where appropriate and supported by technical documentation.

Microgyn, a combined oral contraceptive, is used to prevent pregnancy by influencing the hormonal regulation of the menstrual cycle.

- Contraception: Prevents unintended pregnancy in women of reproductive age. - Menstrual cycle control: Provides scheduled withdrawal bleeding for predictable cycles. - Hormonal regulation: Helps maintain a regular menstrual pattern during use.

Microgyn may cause a range of adverse reactions. Patients should be informed of both common and serious possibilities.

Common Side Effects: - Nausea - Breast tenderness - Headache - Irregular vaginal bleeding

Serious or Rare Side Effects: - Blood clots such as deep‑vein thrombosis or pulmonary embolism - Stroke or transient ischemic attack - Severe allergic reaction (anaphylaxis)

Before prescribing Microgyn, clinicians should evaluate several safety considerations.

- Assess cardiovascular risk: review history of thromboembolic disorders. - Review liver function: avoid in severe hepatic impairment. - Consider smoking status: contraindicated in women over 35 who smoke. - Monitor blood pressure: hormonal effects may raise pressure in some patients. - Avoid use during pregnancy: not indicated for pregnant women. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Microgyn can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine) may reduce contraceptive efficacy. - Rifampin: can markedly lower hormone levels. - Certain protease inhibitors: may increase hormone concentrations.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics such as tetracycline: may slightly diminish effectiveness. - St. John’s wort: may lower contraceptive reliability.